Dominik Cordier

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial

Dominik Cordier, Flavio Forrer, Frank Bruchertseifer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 195 citations

Engineering, Pharmacotherapy, High-grade Gliomas +16

Local Targeting of Malignant Gliomas by the Diffusible Peptidic Vector 1,4,7,10-Tetraazacyclododecane-1-Glutaric Acid-4,7,10-Triacetic Acid-Substance P

Stefan Kneifel, Dominik Cordier, Stephan Good et al. · Clinical Cancer Research · 2006 · 153 citations

⁹⁰Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

Karine Gerster-Gilliéron, Flavio Forrer, Helmut R. Maëcke et al. · Journal of Nuclear Medicine · 2015 · 64 citations · Full text

Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA–substance P—results from a phase I study

Dominik Cordier, Flavio Forrer, Stefan Kneifel et al. · Journal of Neuro-Oncology · 2010 · 60 citations

Neuro-oncology, Radiolabeled Dotaga–substance P—results, Oncology +10

A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers

Dominik Cordier, Catherine Gozé, Sabine Schädelin et al. · Journal of Neuro-Oncology · 2014 · 45 citations

Neuro-oncology, Surgical Oncology, Oncology +14